MRC Cancer Unit
The MRC Cancer Unit's mission is to study the earliest steps in the emergence of cancer, and translate this knowledge to clinical application for the benefit of patients.
The MRC Cancer Unit’s mission is to improve understanding of the earliest steps in epithelial carcinogenesis and to utilize this knowledge in new approaches for clinical intervention through the development of innovative enabling technologies. We believe that improved understanding of the earliest steps in the transformation of normal cells into cancers will lead to new methods to improve the care and survival of patients with common and serious malignancies such as oesophageal, skin, lung, kidney and pancreatic cancer.
The Unit receives core funding from the Medical Research Council, with additional external support from the Wellcome Trust, CRUK and other sponsors. Research at the Unit is conducted in 9 faculty-led programmes and supported by approximately 140 staff.